Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
06/05/2003 | WO2003046010A1 Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance |
06/05/2003 | WO2003046009A1 ANTI-IL13 RECEPTOR α1 NEUTRALIZING ANTIBODY |
06/05/2003 | WO2003046004A2 Macroglobulin biopolymer markers indicative of insulin resistance |
06/05/2003 | WO2003046003A2 Plasma protease c1 biopolymer markers predictive of alzheimers disease |
06/05/2003 | WO2003046001A2 Protein biopolymer markers predictive of insulin resistance |
06/05/2003 | WO2003045999A2 Human vanilloid receptor protein and polynucleotide sequence encoding same |
06/05/2003 | WO2003045993A2 Protein biopolymer markers predictive of type ii diabetes |
06/05/2003 | WO2003045992A1 Cenp-e biopolymer marker indicative of age matched control |
06/05/2003 | WO2003045991A2 Complement c3 precursor biopolymer markers predictive of alzheimers disease |
06/05/2003 | WO2003045990A2 Protein-protein interactions involving transforming growth factor beta signalling |
06/05/2003 | WO2003045984A2 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
06/05/2003 | WO2003045983A1 Apolipoprotein biopolymer markers predictive of type ii diabetes |
06/05/2003 | WO2003045924A1 Substituted aryl 1,4-pyrazine derivatives |
06/05/2003 | WO2003045910A2 Diagnosis of endothelial dysfunction by nitric oxide bioactivity index |
06/05/2003 | WO2003045441A1 Contrast agents for the in vivo detection of enzyme activity |
06/05/2003 | WO2003045425A1 Muscle transcription factors |
06/05/2003 | WO2003045424A1 Methods of compositions for normalizing lipid levels in mammalian tissues |
06/05/2003 | WO2003045422A1 Agonists and antagonists of prolixin for the treatment of metabolic disorders |
06/05/2003 | WO2003045421A1 Agonists and antagonists of ryzn for the treatment of metabolic disorders |
06/05/2003 | WO2003045420A2 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
06/05/2003 | WO2003045321A2 MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE |
06/05/2003 | WO2003045314A2 Mhyps as modifiers of branching morphogenesis and methods of use |
06/05/2003 | WO2003045310A2 Digital assay |
06/05/2003 | WO2003045230A2 Novel compositions and methods for cancer |
06/05/2003 | WO2003045229A2 Methods and compositions for treating cancer |
06/05/2003 | WO2003045227A2 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness |
06/05/2003 | WO2003036258A3 System and method for determining radius of gyration, molecular weight, and intrinsic viscosity of a polymeric distribution using gel permeation chromatography and light-scattering detection |
06/05/2003 | WO2003032234A9 Blood and tissue sample assessment of mitochondrial function and biochemistry as a tool for selection for feed efficiency and other production parameters |
06/05/2003 | WO2003029418A3 Proliferation and differentiation of stem cells using extracellular matrix and other molecules |
06/05/2003 | WO2003027288A9 Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3 |
06/05/2003 | WO2003025224A8 Differential gene expression in schizophrenia |
06/05/2003 | WO2003020952A3 Affinity-shifted probes for quantifying analyte polynucleotides |
06/05/2003 | WO2003020948A3 Fret protease assays for botulinum serotype a/e toxins |
06/05/2003 | WO2003010536A3 Tnf-alpha mimics and lead optimisation |
06/05/2003 | WO2003008929A3 Particle analysis as a detection system for particle-enhanced assays |
06/05/2003 | WO2003008430A3 Porphyrin derivatives for photodynamic therapy |
06/05/2003 | WO2003002764A3 Screening method for identifying cancer therapy-relevant compounds |
06/05/2003 | WO2002103371A3 Magnetic-based placement and retention of sensor elements in a sensor array |
06/05/2003 | WO2002102306A3 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
06/05/2003 | WO2002099118A3 Method of identifying a polymorphism in cyp2d6 |
06/05/2003 | WO2002088750A3 Proteins, genes and their use for diagnosis and treatment of breast cancer |
06/05/2003 | WO2002088396A9 Reagents and methods for automated in situ or microarray hybridization |
06/05/2003 | WO2002086505A3 Intracellular analysis |
06/05/2003 | WO2002084301A3 Screening assay for agents modulating activity of the abca1 protein |
06/05/2003 | WO2002077261A3 Human potassium channel |
06/05/2003 | WO2002074924A3 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
06/05/2003 | WO2002062841A3 Secreted proteins |
06/05/2003 | WO2002061431A3 Screening assay for modulators of syntaxin-sulfonylurea receptor binding |
06/05/2003 | WO2002060932A3 A serpin in bifidobacteria |
06/05/2003 | WO2002059307A3 Human ltrpc7 proteins, nucleic acid molecules encoding them, and uses thereof |
06/05/2003 | WO2002050301A3 Gene expression profiles associated with osteoblast differentiation |
06/05/2003 | WO2002046392A3 X ray crystal structures at 5.5 a resolution of functional complexes of the bacterial ribosome containing transfer rna and model messenger rnas |
06/05/2003 | WO2002046230A3 G-protein coupled receptors |
06/05/2003 | WO2002042330A3 Cystoskeleton-associated proteins |
06/05/2003 | WO2002040510A3 Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors |
06/05/2003 | WO2002036075A3 Small molecule compositions for binding to hsp90 |
06/05/2003 | WO2002034942A3 Nucleic acid amplification-based methods for the determination of a methylation profile and reagents therefor |
06/05/2003 | WO2002031514A3 A method of determining the initial dose of vitamin d compounds |
06/05/2003 | WO2002031507A3 Non-invasive enzyme screen for tissue remodelling-associated conditions |
06/05/2003 | WO2002031179A3 Multiplex assays using nanoparticles |
06/05/2003 | WO2002018633A3 Determination of the ability of patients to respond to tumour treatment |
06/05/2003 | WO2002016635A3 Method for marking chemical substances |
06/05/2003 | US20030105600 Apparatus and method for detecting contamination of object by a metal |
06/05/2003 | US20030105595 Chi square tests for gene expression |
06/05/2003 | US20030105594 cDNA databases for analysis of hematopoietic tissue |
06/05/2003 | US20030105411 Electrical impedance measuring method for differentiating tissue types |
06/05/2003 | US20030105391 Glucose measurement utilizing non-invasive assessment methods |
06/05/2003 | US20030105320 Immobilized fluorescent/luminescent probes; detection of amplicons; transcription associated amplification; polymerases |
06/05/2003 | US20030105318 G-protein transmembrane domain; protein synthesis inhibitor; neurotransmitter |
06/05/2003 | US20030105310 Gram negative bacteria for detecting and isolating random amino acid sequences from ricketsia ricketsii; in situ mutagenesis; vaccine delivery; tumor diagnosis and targeting |
06/05/2003 | US20030105298 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/05/2003 | US20030105292 Continously induced g-protein coupled receptors; membrane binding assays |
06/05/2003 | US20030105285 Odorant receptors |
06/05/2003 | US20030105284 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
06/05/2003 | US20030105280 Such as N-hydroxysuccinimidyl-5-(N,N-bis-(2-(4-(N-((3-hydroxy-4-(methoxy -carbonyl)phenyl)methyl)carbamoyl) butanoylamino)ethyl)carbamoyl)butanoate for biochemical conjugation |
06/05/2003 | US20030105152 Treatments for neurotoxicity in Alzheimer's disease |
06/05/2003 | US20030105111 For use as fluorescence dyes and probes |
06/05/2003 | US20030105057 Modulating the rate and/or amount of a cellular process selected from the group consisting of cell growth, cell detachment and cell migration, and cellular apoptosis by altering the RECEPTOR/PTK-STAT pathway of cell |
06/05/2003 | US20030105024 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals |
06/05/2003 | US20030105004 Novel morphogenic protein compositions of matter |
06/05/2003 | US20030104999 Endorepellin: methods and compositions for inhibiting angiogenesis |
06/05/2003 | US20030104998 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/05/2003 | US20030104987 Methods of using the hyaluronan receptor for endocytosis |
06/05/2003 | US20030104975 Useful for identification of compounds that induce or inhibit the recruitment of the p160 family cofactors, especially TIF-2 and/ or SRCs cofactors (Translation initiation factor-2 and steroid receptor cofactors) |
06/05/2003 | US20030104635 Screening methods |
06/05/2003 | US20030104633 Rapid detection of mutant polypeptide particles in liquid sample using optically labeled peptide; based on conformational changes due to propagation catalysts |
06/05/2003 | US20030104631 Method for preparation of hematology blood control |
06/05/2003 | US20030104630 Hematology reference control |
06/05/2003 | US20030104629 Hematology reference control |
06/05/2003 | US20030104622 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses |
06/05/2003 | US20030104599 Polypeptide (suv39h2) having histone methyltransferase activity; antitumor agents; meiotic chromatin; contraceptives |
06/05/2003 | US20030104595 Oxidoreductase; probes for accurate measurement and detection of glucose concentration in cell |
06/05/2003 | US20030104590 Microfabricated devices for the storage and selective exposure of chemicals and devices |
06/05/2003 | US20030104579 Pluripotent stem cells; antitumor agents; antiproliferative agents; antiinflammatory agents; veterinary medicine; tissue engineering |
06/05/2003 | US20030104569 Proteins suppressing proliferation of lympho-hematopoietic cells |
06/05/2003 | US20030104557 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptides; cancer diagnosis |
06/05/2003 | US20030104556 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/05/2003 | US20030104555 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/05/2003 | US20030104554 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypetide; cancer diagnosis |
06/05/2003 | US20030104550 Secreted and transmembrane polypeptides and nucleic acids encoding the same |